WELLS FARGO & COMPANY/MN - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 58 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 0.43 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2016$0400
+39900.0%
0.00%
Q1 2016$010.0%0.00%
Q4 2015$010.0%0.00%
Q3 2015$010.0%0.00%
Q2 2015$01
-50.0%
0.00%
Q1 2015$0
-100.0%
2
-100.0%
0.00%
Q4 2014$11,0004,785
+478400.0%
0.00%
Q3 2014$010.0%0.00%
Q2 2014$0
-100.0%
1
-100.0%
0.00%
Q1 2014$118,00010,009
+1000800.0%
0.00%
Q4 2013$010.0%0.00%
Q3 2013$010.0%0.00%
Q2 2013$010.00%
Other shareholders

There were no reported owners of ONCOGENEX PHARMACEUTICALS IN in Q2 2015.

NameSharesValueWeighting ↓
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders